Picture of Pangaea Oncology SA logo

PANG Pangaea Oncology SA Cashflow Statement

0.000.00%
es flag iconLast trade - 00:00
HealthcareConservativeMicro CapMomentum Trap

Annual cashflow statement for Pangaea Oncology SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
SAS
SAS
SAS
SAS
SAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-1.1-2.84-3.51-1.69-4.02
Depreciation
Amortisation
Non-Cash Items-1.52-1.88-1.41-2.71-2.07
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-0.873-0.1950.702-2.720.793
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-2.5-3.68-2.4-4.57-2.52
Capital Expenditures-0.03-0.02-0.291-0.52-0.472
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.768-0.725-1.290.2450.029
Acquisition of Business
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-0.797-0.746-1.58-0.275-0.443
Financing Cash Flow Items0.067
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities5.089.5-1.746.791.6
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1.775.08-5.721.95-1.36